课题基金 / 基金详情

A New Molecular Mechanism to Bioengineering a Liver

A New Molecular Mechanism to Bioengineering a Liver
肝脏生物工程的新分子机制
批准号:
10359794
负责人:
ERIC LAGASSE
金额:
$40.85万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2024-03-31

项目摘要

项目成果

ERIC LAGASSE的其他基金

相似基金

相关文献

中文摘要
翻译
肝细胞移植有许多潜在的应用。大量的动物
英文摘要
Hepatocyte transplantation has many potential applications. Extensive animal experiments have shown that hepatocytes transplanted in the liver or at ectopic sites survive, function, and actively participate in the regenerative process. However our understanding of hepatocyte engraftment and their remarkable proliferative and regenerative potential is limited, even if primary hepatocyte transplantation is at the doorstep of applications in the treatment of inherited and acquired human diseases. We previously made a serendipitous observation that normal hepatocytes transplanted in the peritoneal cavity of an animal with lethal liver disease migrate into the lymphatic system and engineer ectopic liver-like organoids that rescue an animal model from a fatal metabolic disorder. How hepatocytes enter the lymphatics and what molecular mechanism is responsible for the generation of ectopic mass is not known. We hypothesized that hepatocytes must borrow some of the molecular mechanism lymphocytes use to migrate into the lymphatics. Our interest will be to study ectopic cell transplantation and our central objective of our application is to translate a highly interesting observation, the generation of ectopic liver, to a potential clinical application for patients with liver diseases.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Organogenesis of Ectopic Tissue in Lymph Node
Organogenesis of Ectopic Tissue in Lymph Node
Organogenesis of Ectopic Tissue in Lymph Node
Organogenesis of Ectopic Tissue in Lymph Node
海外基金